Mesenchymal Stem Cells Decrease Lung Inflammation During Sepsis, Acting Through Inhibition of the MAPK Pathway
Stem Cell Research and Therapy - United Kingdom
doi 10.1186/s13287-017-0734-8
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2017
Authors
Publisher
Springer Science and Business Media LLC